{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:57:56Z","timestamp":1794337076631,"version":"4.9.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"crossref","award":["2020-05494"],"award-info":[{"award-number":["2020-05494"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001728","name":"Swedish Foundation for International Cooperation in Research and Higher Education","doi-asserted-by":"crossref","award":["AF 2020"],"award-info":[{"award-number":["AF 2020"]}],"id":[{"id":"10.13039\/501100001728","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","award":["SLS-974353"],"award-info":[{"award-number":["SLS-974353"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The prevalence of lifestyle-associated diseases is increasing in sub-Saharan Africa. This study investigated the prevalence of metabolic co-morbidities in adults with malaria and whether type 2 diabetes, obesity, and metabolic syndrome (Met-S) affect the severity of malaria in adults living in a malaria-endemic setting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a cross-sectional study with prospective inclusion of patients at two tertiary-level public hospitals in Bafoussam and Dschang (West Region, Cameroon). Adults (\u2265\u200921\u00a0years) diagnosed with malaria were included. Malaria severity was determined following the WHO criteria. All patients were assessed for diabetes, obesity, and Met-S, according to the International Diabetes Federation. Additional host factors investigated included age, sex, HIV infection, sickle cell trait and blood group. Multivariable logistic regression was used to assess potential associations with severe malaria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 289 adults diagnosed with <jats:italic>P. falciparum<\/jats:italic> malaria, 120 (41.6%) fulfilled at least one criterion for severe malaria. Diabetes was found in 26\/120 (21.7%) of patients with severe and 10\/169 (6.0%) with non-severe malaria (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Met-S was diagnosed in 39\/120 (32.5%) severe and 27\/166 (16.3%) non-severe cases, respectively (<jats:italic>p<\/jats:italic>\u2009=\u20090.001). Obesity was similarly detected in severe (23\/103; 22.3%) and non-severe cases (34\/148; 23.0%). In multivariable analyses, diabetes (aOR\u2009=\u20093.24; 95%CI, 1.38\u20147.62) and Met-S (aOR\u2009=\u20093.18; 95%CI, 1.60\u20146.37) were independently associated with severe malaria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>A high prevalence of diabetes and metabolic comorbidities was found among adults diagnosed with malaria in hospital settings in an endemic area. Diabetes and metabolic syndrome, but not obesity alone, were identified as risk factors for severe malaria. Investigation for diabetes should be considered in adults with severe malaria.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12879-025-11389-1","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T12:50:40Z","timestamp":1755867040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diabetes and metabolic syndrome in adults with malaria and associations with severe disease: results\u00a0from two tertiary hospitals in Cameroon"],"prefix":"10.1186","volume":"25","author":[{"given":"George","family":"Awungafac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain Raoul Simeni","family":"Njonnou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Noubom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila Ingrid Angeline Avezo\u2019o","family":"Libon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Ngunyi","family":"Gesu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"F\u00e4rnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sim\u00e9on Pierre","family":"Choukem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Wyss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"11389_CR1","unstructured":"World Health Organisation Africa. Noncommunicable Diseases. World Health Organization: Regional Office for Africa Retrieved from afrowhoint\/health-topics\/noncommunicablediseases. 2017."},{"issue":"4","key":"11389_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41574-021-00613-y","volume":"18","author":"AA Motala","year":"2022","unstructured":"Motala AA, Mbanya JC, Ramaiya K, Pirie FJ, Ekoru K. Type 2 diabetes mellitus in sub-Saharan Africa: challenges and opportunities. Nat Rev Endocrinol. 2022;18(4):219\u201329.","journal-title":"Nat Rev Endocrinol"},{"key":"11389_CR3","unstructured":"International Diabetes Federation. IDF Diabetes Atlas 11th Edition 2025. 2025."},{"issue":"8","key":"11389_CR4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S2213-8587(17)30181-X","volume":"5","author":"R Atun","year":"2017","unstructured":"Atun R, Davies JI, Gale EAM, B\u00e4rnighausen T, Beran D, Kengne AP, et al. Diabetes in sub-Saharan Africa: from clinical care to health policy. Lancet Diabetes Endocrinol. 2017;5(8):622\u201367.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"11389_CR5","unstructured":"World malaria report 2024: addressing inequity in the global malaria response. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"11389_CR6","doi-asserted-by":"crossref","unstructured":"Calvet HM, Yoshikawa TT. Infections in diabetes. Infect Dis Clin North Am. 2001;15(2):407\u201321, viii.","DOI":"10.1016\/S0891-5520(05)70153-7"},{"issue":"10","key":"11389_CR7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/j.1464-5491.1994.tb00250.x","volume":"11","author":"P Pozzilli","year":"1994","unstructured":"Pozzilli P, Leslie RD. Infections and diabetes: mechanisms and prospects for prevention. Diabet Med. 1994;11(10):935\u201341.","journal-title":"Diabet Med"},{"issue":"7","key":"11389_CR8","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2337\/dc09-2215","volume":"33","author":"R Allard","year":"2010","unstructured":"Allard R, Leclerc P, Tremblay C, Tannenbaum T-N. Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care. 2010;33(7):1491\u20133.","journal-title":"Diabetes Care"},{"key":"11389_CR9","doi-asserted-by":"crossref","unstructured":"Dicembrini I, Silverii GA, Clerico A, Fornengo R, Gabutti G, Sordi V, et al. Influenza: Diabetes as a risk factor for severe related-outcomes and the effectiveness of vaccination in diabetic population. A meta-analysis of observational studies. Nutr Metab Cardiovasc Dis. 2023;33(6):1099\u2013110.","DOI":"10.1016\/j.numecd.2023.03.016"},{"issue":"11","key":"11389_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19116555","volume":"19","author":"T G\u0119ca","year":"2022","unstructured":"G\u0119ca T, Wojtowicz K, Guzik P, G\u00f3ra T. Increased risk of COVID-19 in patients with diabetes mellitus\u2014current challenges in pathophysiology, treatment and prevention. Int J Environ Res Public Health. 2022;19(11): 6555.","journal-title":"Int J Environ Res Public Health"},{"key":"11389_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy030","author":"SI Pitts","year":"2018","unstructured":"Pitts SI, Maruthur NM, Langley GE, Pondo T, Shutt KA, Hollick R, et al. Obesity, diabetes, and the risk of invasive group B streptococcal disease in nonpregnant adults in the United States. Open Forum Infect Dis. 2018. https:\/\/doi.org\/10.1093\/ofid\/ofy030.","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"11389_CR12","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3201\/eid1610.100399","volume":"16","author":"I Danquah","year":"2010","unstructured":"Danquah I, Bedu-Addo G, Mockenhaupt FP. Type 2 diabetes mellitus and increased risk for malaria infection. Emerg Infect Dis. 2010;16(10):1601\u20134.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"11389_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280981","volume":"18","author":"AO Ibrahim","year":"2023","unstructured":"Ibrahim AO, Bello IS, Ajetunmobi AO, Ayodapo A, Afolabi BA, Adeniyi MA. Prevalence of asymptomatic malaria infection by microscopy and its determinants among residents of Ido-Ekiti, Southwestern Nigeria. PLoS ONE. 2023;18(2): e0280981.","journal-title":"PLoS ONE"},{"issue":"6","key":"11389_CR14","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/cid\/cix437","volume":"65","author":"K Wyss","year":"2017","unstructured":"Wyss K, W\u00e5ngdahl A, Vesterlund M, Hammar U, Dashti S, Naucler P, et al. Obesity and diabetes as risk factors for severe Plasmodium falciparum malaria: results from a Swedish nationwide study. Clin Infect Dis. 2017;65(6):949\u201358.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"11389_CR15","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/oby.22566","volume":"27","author":"JR Nansseu","year":"2019","unstructured":"Nansseu JR, Noubiap JJ, Bigna JJ. Epidemiology of overweight and obesity in adults living in Cameroon: a systematic review and meta-analysis. Obesity. 2019;27(10):1682\u201392.","journal-title":"Obesity"},{"key":"11389_CR16","unstructured":"WHO Guidelines for malaria, 25 November 2022. Geneva: World Health Organization; 2022 (WHO\/UCN\/GMP\/2022.01 Rev.3). License: CC BY-NC-SA 3.0 IGO."},{"key":"11389_CR17","doi-asserted-by":"crossref","unstructured":"Godman B, Basu D, Pillay Y, Mwita JC, Rwegerera GM, Anand Paramadhas BD, et al. Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future. Frontiers in Pharmacology. 2020;11.","DOI":"10.3389\/fphar.2020.00108"},{"key":"11389_CR18","unstructured":"A healthy lifestyle - WHO recommendations 6 May 2010 [Available from: https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/a-healthy-lifestyle---who-recommendations."},{"key":"11389_CR19","unstructured":"Federation ID. IDF consensus worldwide definition of the metabolic syndrome. 2006."},{"issue":"8","key":"11389_CR20","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1086\/374224","volume":"36","author":"N Muhlberger","year":"2003","unstructured":"Muhlberger N, Jelinek T, Behrens RH, Gjorup I, Coulaud JP, Clerinx J, et al. Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID surveillance data. Clin Infect Dis. 2003;36(8):990\u20135.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"11389_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1055\/s-2003-37247","volume":"128","author":"A Stich","year":"2003","unstructured":"Stich A, Zwicker M, Steffen T, K\u00f6hler B, Fleischer K. Old age as risk factor for complications of malaria in non-immune travellers. Dtsch Med Wochenschr. 2003;128(7):309\u201314.","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"11389_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/sjmms.sjmms_178_18","volume":"8","author":"BE Udoh","year":"2020","unstructured":"Udoh BE, Iwalokun BA, Etukumana E, Amoo J. Asymptomatic falciparum malaria and its effects on type 2 diabetes mellitus patients in Lagos, Nigeria. Saudi J Med Med Sci. 2020;8(1):32\u201340.","journal-title":"Saudi J Med Med Sci"},{"key":"11389_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s40608-016-0126-0","author":"TN Haregu","year":"2016","unstructured":"Haregu TN, Oti S, Egondi T, Kyobutungi C. Measurement of overweight and obesity an urban slum setting in sub-Saharan Africa: a comparison of four anthropometric indices. BMC Obes. 2016. https:\/\/doi.org\/10.1186\/s40608-016-0126-0.","journal-title":"BMC Obes"},{"key":"11389_CR24","unstructured":"Organisation WH. The Asian perspective: Redefining obesity and its treatment 2000 [Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/206936\/0957708211_eng.pdf."},{"issue":"2","key":"11389_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.idh.2018.01.002","volume":"23","author":"D Khuu","year":"2018","unstructured":"Khuu D, Eberhard ML, Bristow BN, Javanbakht M, Ash LR, Shafir SC, et al. Risk factors for severe malaria among hospitalized patients in the United States, 2000\u20132014. Infect Dis Health. 2018;23(2):93\u2013106.","journal-title":"Infect Dis Health"},{"issue":"3","key":"11389_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1086\/431587","volume":"41","author":"LM Muller","year":"2005","unstructured":"Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41(3):281\u20138.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"11389_CR27","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1177\/193229680800200622","volume":"2","author":"YI Cho","year":"2008","unstructured":"Cho YI, Mooney MP, Cho DJ. Hemorheological disorders in diabetes mellitus. J Diabetes Sci Technol. 2008;2(6):1130\u20138.","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"11389_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249666","volume":"16","author":"JH Ch'ng","year":"2021","unstructured":"Ch\u2019ng JH, Moll K, Wyss K, Hammar U, Ryden M, Kampe O, et al. Enhanced virulence of Plasmodium falciparum in blood of diabetic patients. PLoS ONE. 2021;16(6): e0249666.","journal-title":"PLoS ONE"},{"issue":"7","key":"11389_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S1473-3099(11)70031-7","volume":"11","author":"C Flateau","year":"2011","unstructured":"Flateau C, Le Loup G, Pialoux G. Consequences of HIV infection on malaria and therapeutic implications: a systematic review. Lancet Infect Dis. 2011;11(7):541\u201356.","journal-title":"Lancet Infect Dis"},{"issue":"28","key":"11389_CR30","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.1073\/pnas.1804388115","volume":"115","author":"NM Archer","year":"2018","unstructured":"Archer NM, Petersen N, Clark MA, Buckee CO, Childs LM, Duraisingh MT. Resistance to Plasmodium falciparum in sickle cell trait erythrocytes is driven by oxygen-dependent growth inhibition. Proc Natl Acad Sci USA. 2018;115(28):7350\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"11389_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-309","volume":"10","author":"AK Panda","year":"2011","unstructured":"Panda AK, Panda SK, Sahu AN, Tripathy R, Ravindran B, Das BK. Association of ABO blood group with severe falciparum malaria in adults: case control study and meta-analysis. Malar J. 2011;10(1): 309.","journal-title":"Malar J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11389-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11389-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11389-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:16:32Z","timestamp":1757416592000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11389-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11389"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11389-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"6 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the National Ethics Committee of Research for Human Health, Yaounde (2021\/11\/1405\/CE\/CNERSH\/SP, 2023\/02\/1524\/CE\/CNERSH\/SP), and the Ethical Review Board in Stockholm, Sweden (2022\u201305379-01). It was performed according to the Declaration of Helsinki, a set of principles that guide medical research involving human subjects. Written informed consent was obtained from all the participants and the legal guardians of the illiterate participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1060"}}